$MRK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Merck & Co., Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Merck & Co., Inc.. Get notifications about new insider transactions in Merck & Co., Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | MRK | Merck & Co., Inc. | Warden Kathy J | Director | Option Exercise | A | 0.00 | 2,635 | 0 | 5,310 | |
Jun 02 2021 | MRK | Merck & Co., Inc. | Rothman Paul | Director | Option Exercise | A | 0.00 | 2,635 | 0 | 19,522 | |
Jun 02 2021 | MRK | Merck & Co., Inc. | BRUN LESLIE A | Director | Option Exercise | A | 0.00 | 2,635 | 0 | 49,719 | |
May 11 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP & Pres ? Human ... | Option Exercise | M | 44.98 | 19,324 | 869,194 | 19,323 | |
May 11 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP & Pres ? Human ... | Sell | S | 78.32 | 19,324 | 1,513,440 | 94,348 | 113.7 K to 94.3 K (-17.00 %) |
May 11 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP & Pres ? Human ... | Buy | M | 0.00 | 19,324 | 0 | 113,672 | 94.3 K to 113.7 K (+20.48 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Option Exercise | M | 0.00 | 417 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Option Exercise | A | 75.99 | 33,673 | 2,558,811 | 33,673 | |
May 06 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Payment of Exercise | F | 75.98 | 143 | 10,865 | 5,519 | 5.7 K to 5.5 K (-2.53 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Buy | M | 75.98 | 417 | 31,684 | 5,662 | 5.2 K to 5.7 K (+7.95 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Karachun Rita A | Sr. VP Fince-Global ... | Option Exercise | M | 0.00 | 1,212 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | Karachun Rita A | Sr. VP Fince-Global ... | Option Exercise | A | 0.00 | 2,764 | 0 | 2,764 | |
May 06 2021 | MRK | Merck & Co., Inc. | Karachun Rita A | Sr. VP Fince-Global ... | Option Exercise | A | 75.99 | 21,429 | 1,628,390 | 21,429 | |
May 06 2021 | MRK | Merck & Co., Inc. | Karachun Rita A | Sr. VP Fince-Global ... | Payment of Exercise | F | 75.98 | 416 | 31,608 | 35,799 | 36.2 K to 35.8 K (-1.15 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Karachun Rita A | Sr. VP Fince-Global ... | Buy | M | 75.98 | 1,212 | 92,088 | 36,215 | 35 K to 36.2 K (+3.46 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Option Exercise | M | 0.00 | 1,039 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Option Exercise | A | 75.99 | 67,347 | 5,117,699 | 67,347 | |
May 06 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Payment of Exercise | F | 75.98 | 489 | 37,154 | 19,741 | 20.2 K to 19.7 K (-2.42 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Buy | M | 75.98 | 1,039 | 78,943 | 20,230 | 19.2 K to 20.2 K (+5.41 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Option Exercise | M | 0.00 | 694 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Option Exercise | A | 75.99 | 91,837 | 6,978,694 | 91,837 | |
May 06 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Payment of Exercise | F | 75.98 | 238 | 18,083 | 12,310 | 12.5 K to 12.3 K (-1.90 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Buy | M | 75.98 | 694 | 52,730 | 12,548 | 11.9 K to 12.5 K (+5.85 %) |
May 06 2021 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Option Exercise | A | 75.99 | 64,286 | 4,885,093 | 64,286 | |
May 06 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Option Exercise | M | 0.00 | 5,772 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Option Exercise | A | 75.99 | 82,653 | 6,280,801 | 82,653 | |
May 06 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Payment of Exercise | F | 75.98 | 2,843 | 216,011 | 34,141 | 37 K to 34.1 K (-7.69 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Buy | M | 75.98 | 5,772 | 438,557 | 36,984 | 31.2 K to 37 K (+18.49 %) |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Option Exercise | M | 0.00 | 694 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Option Exercise | A | 0.00 | 2,369 | 0 | 2,369 | |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Option Exercise | A | 75.99 | 18,367 | 1,395,708 | 18,367 | |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Payment of Exercise | F | 75.98 | 238 | 18,083 | 2,374 | 2.6 K to 2.4 K (-9.11 %) |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Buy | M | 75.98 | 694 | 52,730 | 2,612 | 1.9 K to 2.6 K (+36.18 %) |
May 06 2021 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Option Exercise | A | 75.99 | 64,286 | 4,885,093 | 64,286 | |
May 06 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Option Exercise | M | 0.00 | 5,772 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Option Exercise | A | 75.99 | 82,653 | 6,280,801 | 82,653 | |
May 06 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Payment of Exercise | F | 75.98 | 2,843 | 216,011 | 34,141 | 37 K to 34.1 K (-7.69 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Buy | M | 75.98 | 5,772 | 438,557 | 36,984 | 31.2 K to 37 K (+18.49 %) |
May 06 2021 | MRK | Merck & Co., Inc. | DeLuca Richard R. | EVP&Pres, Merck Ani ... | Option Exercise | A | 75.99 | 82,653 | 6,280,801 | 82,653 | |
May 06 2021 | MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI ... | Option Exercise | A | 75.99 | 39,796 | 3,024,098 | 39,796 | |
May 06 2021 | MRK | Merck & Co., Inc. | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Option Exercise | A | 75.99 | 85,714 | 6,513,407 | 85,714 | |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Option Exercise | M | 0.00 | 694 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Option Exercise | A | 0.00 | 2,369 | 0 | 2,369 | |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Option Exercise | A | 75.99 | 18,367 | 1,395,708 | 18,367 | |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Payment of Exercise | F | 75.98 | 238 | 18,083 | 2,374 | 2.6 K to 2.4 K (-9.11 %) |
May 06 2021 | MRK | Merck & Co., Inc. | LeCointe-Cephas Lisa | SVP Chief Ethics & ... | Buy | M | 75.98 | 694 | 52,730 | 2,612 | 1.9 K to 2.6 K (+36.18 %) |
May 06 2021 | MRK | Merck & Co., Inc. | DeLuca Richard R. | EVP&Pres, Merck Ani ... | Option Exercise | A | 75.99 | 82,653 | 6,280,801 | 82,653 | |
May 06 2021 | MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI ... | Option Exercise | A | 75.99 | 39,796 | 3,024,098 | 39,796 | |
May 06 2021 | MRK | Merck & Co., Inc. | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Option Exercise | A | 75.99 | 85,714 | 6,513,407 | 85,714 | |
May 06 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 1,906 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | A | 75.99 | 131,633 | 10,002,792 | 131,633 | |
May 06 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 75.98 | 939 | 71,345 | 94,348 | 95.3 K to 94.3 K (-0.99 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 75.98 | 1,906 | 144,818 | 95,287 | 93.4 K to 95.3 K (+2.04 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Davis Robert M | President | Option Exercise | A | 75.99 | 281,633 | 21,401,292 | 281,633 | |
May 04 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Option Exercise | M | 0.00 | 750 | 0 | 750 | |
May 04 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Option Exercise | M | 0.00 | 840 | 0 | 1,680 | |
May 04 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Payment of Exercise | F | 74.50 | 353 | 26,299 | 19,191 | 19.5 K to 19.2 K (-1.81 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Buy | M | 74.50 | 750 | 55,875 | 19,544 | 18.8 K to 19.5 K (+3.99 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Payment of Exercise | F | 74.50 | 288 | 21,456 | 18,794 | 19.1 K to 18.8 K (-1.51 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Litchfield Caroline | EVP & CFO | Buy | M | 74.50 | 840 | 62,580 | 19,082 | 18.2 K to 19.1 K (+4.60 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Option Exercise | M | 0.00 | 750 | 0 | 750 | |
May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Option Exercise | M | 0.00 | 1,030 | 0 | 2,060 | |
May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Payment of Exercise | F | 74.50 | 257 | 19,147 | 11,854 | 12.1 K to 11.9 K (-2.12 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Buy | M | 74.50 | 750 | 55,875 | 12,111 | 11.4 K to 12.1 K (+6.60 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Payment of Exercise | F | 74.50 | 354 | 26,373 | 11,361 | 11.7 K to 11.4 K (-3.02 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Buy | M | 74.50 | 1,030 | 76,735 | 11,715 | 10.7 K to 11.7 K (+9.64 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Option Exercise | M | 0.00 | 412 | 0 | 414 | |
May 04 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Option Exercise | M | 0.00 | 560 | 0 | 1,120 | |
May 04 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Payment of Exercise | F | 74.50 | 142 | 10,579 | 5,245 | 5.4 K to 5.2 K (-2.64 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Buy | M | 74.50 | 412 | 30,694 | 5,387 | 5 K to 5.4 K (+8.28 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Payment of Exercise | F | 74.50 | 192 | 14,304 | 4,975 | 5.2 K to 5 K (-3.72 %) |
May 04 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Buy | M | 74.50 | 560 | 41,720 | 5,167 | 4.6 K to 5.2 K (+12.16 %) |
Apr 01 2021 | MRK | Merck & Co., Inc. | WENDELL PETER C | Director | Option Exercise | A | 0.00 | 389 | 0 | 100,545 | |
Apr 01 2021 | MRK | Merck & Co., Inc. | Seidman Christine E | Director | Option Exercise | A | 0.00 | 211 | 0 | 3,510 | |
Apr 01 2021 | MRK | Merck & Co., Inc. | Coe Mary Ellen | Director | Option Exercise | A | 0.00 | 422 | 0 | 8,337 | |
Mar 17 2021 | MRK | Merck & Co., Inc. | Mayo Stephen | Director | Option Exercise | A | 0.00 | 120 | 0 | 120 | |
Mar 02 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Grant | A | 72.62 | 3,485 | 253,081 | 10,655 | 7.2 K to 10.7 K (+48.61 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Williams David Michael | EVP,Chief Info&Digi ... | Grant | A | 72.62 | 2,090 | 151,776 | 4,583 | 2.5 K to 4.6 K (+83.83 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Karachun Rita A | Sr. VP Fince-Global ... | Grant | A | 72.62 | 6,052 | 439,496 | 33,836 | 27.8 K to 33.8 K (+21.78 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Grant | A | 72.62 | 17,830 | 1,294,815 | 23,181 | 5.4 K to 23.2 K (+333.21 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Zachary Jennifer | EVP, General Counse ... | Grant | A | 72.62 | 24,199 | 1,757,331 | 30,947 | 6.7 K to 30.9 K (+358.61 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Davis Robert M | EVP, Global Svcs & ... | Grant | A | 72.62 | 46,641 | 3,387,069 | 217,697 | 171.1 K to 217.7 K (+27.27 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Grant | A | 72.62 | 25,772 | 1,871,563 | 93,145 | 67.4 K to 93.1 K (+38.25 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Grant | A | 72.62 | 9,432 | 684,952 | 92,589 | 83.2 K to 92.6 K (+11.34 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Nally Michael | EVP, Chief Marketin ... | Grant | A | 72.62 | 7,127 | 517,563 | 19,630 | 12.5 K to 19.6 K (+57.00 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Fleming Michael | SVP Chief Ethics & ... | Grant | A | 72.62 | 3,437 | 249,595 | 10,283 | 6.8 K to 10.3 K (+50.20 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | FRAZIER KENNETH C | Chairman, President ... | Grant | A | 72.62 | 175,249 | 12,726,582 | 586,795 | 411.5 K to 586.8 K (+42.58 %) |
Jan 05 2021 | MRK | Merck & Co., Inc. | Coe Mary Ellen | Director | Option Exercise | A | 0.00 | 397 | 0 | 7,857 | |
Jan 05 2021 | MRK | Merck & Co., Inc. | Coe Mary Ellen | Director | Option Exercise | A | 0.00 | 397 | 0 | 7,857 | |
Jan 05 2021 | MRK | Merck & Co., Inc. | WENDELL PETER C | Director | Option Exercise | A | 0.00 | 367 | 0 | 99,381 | |
Nov 03 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 2,287 | 0 | 2,288 | |
Nov 03 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 75.89 | 1,137 | 86,287 | 82,519 | 83.7 K to 82.5 K (-1.36 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 75.89 | 2,287 | 173,560 | 83,656 | 81.4 K to 83.7 K (+2.81 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | Nally Michael | EVP, Chief Marketin ... | Option Exercise | M | 0.00 | 2,287 | 0 | 2,288 | |
Nov 03 2020 | MRK | Merck & Co., Inc. | Nally Michael | EVP, Chief Marketin ... | Payment of Exercise | F | 75.89 | 995 | 75,511 | 12,408 | 13.4 K to 12.4 K (-7.42 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | Nally Michael | EVP, Chief Marketin ... | Buy | M | 75.89 | 2,287 | 173,560 | 13,403 | 11.1 K to 13.4 K (+20.57 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | Nally Michael | EVP, Chief Marketin ... | Option Exercise | M | 0.00 | 2,287 | 0 | 2,288 | |
Nov 03 2020 | MRK | Merck & Co., Inc. | Nally Michael | EVP, Chief Marketin ... | Payment of Exercise | F | 75.89 | 995 | 75,511 | 12,408 | 13.4 K to 12.4 K (-7.42 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | Nally Michael | EVP, Chief Marketin ... | Buy | M | 75.89 | 2,287 | 173,560 | 13,403 | 11.1 K to 13.4 K (+20.57 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Option Exercise | M | 0.00 | 4,574 | 0 | 4,575 | |
Nov 03 2020 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Payment of Exercise | F | 75.89 | 2,273 | 172,498 | 5,351 | 7.6 K to 5.4 K (-29.81 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Buy | M | 75.89 | 4,574 | 347,121 | 7,624 | 3.1 K to 7.6 K (+149.97 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Option Exercise | M | 0.00 | 4,574 | 0 | 4,575 | |
Nov 03 2020 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Payment of Exercise | F | 75.89 | 2,273 | 172,498 | 5,351 | 7.6 K to 5.4 K (-29.81 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | MIZELL STEVEN | EVP, Chief HR Offic ... | Buy | M | 75.89 | 4,574 | 347,121 | 7,624 | 3.1 K to 7.6 K (+149.97 %) |
Oct 06 2020 | MRK | Merck & Co., Inc. | Davis Robert M | EVP, Global Svcs & ... | Option Exercise | M | 54.68 | 251,273 | 13,739,608 | 0 | |
Oct 06 2020 | MRK | Merck & Co., Inc. | Davis Robert M | EVP, Global Svcs & ... | Sell | S | 81.03 | 251,273 | 20,360,325 | 171,056 | 422.3 K to 171.1 K (-59.50 %) |
Oct 06 2020 | MRK | Merck & Co., Inc. | Davis Robert M | EVP, Global Svcs & ... | Buy | M | 0.00 | 251,273 | 0 | 422,329 | 171.1 K to 422.3 K (+146.90 %) |
Oct 06 2020 | MRK | Merck & Co., Inc. | Davis Robert M | EVP, Global Svcs & ... | Option Exercise | M | 54.68 | 251,273 | 13,739,608 | 0 | |
Oct 06 2020 | MRK | Merck & Co., Inc. | Davis Robert M | EVP, Global Svcs & ... | Sell | S | 81.03 | 251,273 | 20,360,325 | 171,056 | 422.3 K to 171.1 K (-59.50 %) |
Oct 06 2020 | MRK | Merck & Co., Inc. | Davis Robert M | EVP, Global Svcs & ... | Buy | M | 0.00 | 251,273 | 0 | 422,329 | 171.1 K to 422.3 K (+146.90 %) |
Oct 02 2020 | MRK | Merck & Co., Inc. | Seidman Christine E | Director | Option Exercise | A | 0.00 | 196 | 0 | 3,054 | |
Oct 02 2020 | MRK | Merck & Co., Inc. | WENDELL PETER C | Director | Option Exercise | A | 0.00 | 362 | 0 | 98,268 | |
Oct 02 2020 | MRK | Merck & Co., Inc. | Coe Mary Ellen | Director | Option Exercise | A | 0.00 | 392 | 0 | 7,406 | |
Aug 17 2020 | MRK | Merck & Co., Inc. | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Sell | S | 83.01 | 10,380 | 861,676 | 67,373 | 77.8 K to 67.4 K (-13.35 %) |
Aug 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 39.29 | 18,876 | 741,638 | 0 | |
Aug 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Sell | S | 81.55 | 18,876 | 1,539,274 | 80,763 | 99.6 K to 80.8 K (-18.94 %) |
Aug 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 0.00 | 18,876 | 0 | 99,639 | 80.8 K to 99.6 K (+23.37 %) |
Jul 20 2020 | MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI ... | Option Exercise | M | 54.68 | 18,111 | 990,309 | 0 | |
Jul 20 2020 | MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI ... | Sell | S | 80.01 | 18,174 | 1,454,096 | 26,577 | 44.8 K to 26.6 K (-40.61 %) |
Jul 20 2020 | MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI ... | Sell | S | 80.00 | 18,111 | 1,448,880 | 44,751 | 62.9 K to 44.8 K (-28.81 %) |
Jul 20 2020 | MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI ... | Buy | M | 0.00 | 18,111 | 0 | 62,862 | 44.8 K to 62.9 K (+40.47 %) |
Jul 02 2020 | MRK | Merck & Co., Inc. | WENDELL PETER C | Director | Option Exercise | A | 0.00 | 388 | 0 | 97,157 | |
Jul 02 2020 | MRK | Merck & Co., Inc. | Seidman Christine E | Director | Option Exercise | A | 0.00 | 210 | 0 | 2,838 | |
Jul 02 2020 | MRK | Merck & Co., Inc. | Coe Mary Ellen | Director | Option Exercise | A | 0.00 | 420 | 0 | 6,964 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | Thulin Inge G | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 10,326 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | Warden Kathy J | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 2,592 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | WENDELL PETER C | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 96,769 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | Craig Pamela J. | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 16,362 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | RUSSO PATRICIA F | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 38,522 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | Rothman Paul | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 16,362 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | GLOCER THOMAS H | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 71,001 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | Coe Mary Ellen | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 6,544 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | Cech Thomas R | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 40,238 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | BRUN LESLIE A | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 45,619 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | Seidman Christine E | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 2,628 | |
Jun 02 2020 | MRK | Merck & Co., Inc. | LAVIZZO-MOUREY RISA J | Director | Option Exercise | A | 0.00 | 2,478 | 0 | 2,478 | |
May 07 2020 | MRK | Merck & Co., Inc. | WEEKS WENDELL P | Director | Option Exercise | M | 35.19 | 5,000 | 175,950 | 0 | |
May 07 2020 | MRK | Merck & Co., Inc. | WEEKS WENDELL P | Director | Option Exercise | M | 35.19 | 5,000 | 175,950 | 0 | |
May 07 2020 | MRK | Merck & Co., Inc. | WEEKS WENDELL P | Director | Sell | S | 76.02 | 5,000 | 380,104 | 100 | 5.1 K to 100 (-98.04 %) |
May 07 2020 | MRK | Merck & Co., Inc. | WEEKS WENDELL P | Director | Sell | S | 76.02 | 5,000 | 380,104 | 100 | 5.1 K to 100 (-98.04 %) |
May 07 2020 | MRK | Merck & Co., Inc. | WEEKS WENDELL P | Director | Buy | M | 0.00 | 5,000 | 0 | 5,100 | 100 to 5.1 K (+5,000.00 %) |
May 07 2020 | MRK | Merck & Co., Inc. | WEEKS WENDELL P | Director | Buy | M | 0.00 | 5,000 | 0 | 5,100 | 100 to 5.1 K (+5,000.00 %) |
May 07 2020 | MRK | Merck & Co., Inc. | BRUN LESLIE A | Director | Option Exercise | M | 35.19 | 5,000 | 175,950 | 0 | |
May 07 2020 | MRK | Merck & Co., Inc. | BRUN LESLIE A | Director | Option Exercise | M | 35.19 | 5,000 | 175,950 | 0 | |
May 07 2020 | MRK | Merck & Co., Inc. | BRUN LESLIE A | Director | Sell | S | 75.46 | 5,000 | 377,300 | 1,948 | 6.9 K to 1.9 K (-71.96 %) |
May 07 2020 | MRK | Merck & Co., Inc. | BRUN LESLIE A | Director | Sell | S | 75.46 | 5,000 | 377,300 | 1,948 | 6.9 K to 1.9 K (-71.96 %) |
May 07 2020 | MRK | Merck & Co., Inc. | BRUN LESLIE A | Director | Buy | M | 0.00 | 5,000 | 0 | 6,948 | 1.9 K to 6.9 K (+256.67 %) |
May 07 2020 | MRK | Merck & Co., Inc. | BRUN LESLIE A | Director | Buy | M | 0.00 | 5,000 | 0 | 6,948 | 1.9 K to 6.9 K (+256.67 %) |
May 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 3,752 | 0 | 0 |